Cullin 4A associates with the UV-damaged DNA-binding protein DDB P Shiyanov, A Nag, P Raychaudhuri Journal of Biological Chemistry 274 (50), 35309-35312, 1999 | 223 | 1999 |
The xeroderma pigmentosum group E gene product DDB2 is a specific target of cullin 4A in mammalian cells A Nag, T Bondar, S Shiv, P Raychaudhuri Molecular and cellular biology, 2001 | 203 | 2001 |
The p48 subunit of the damaged-DNA binding protein DDB associates with the CBP/p300 family of histone acetyltransferase A Datta, S Bagchi, A Nag, P Shiyanov, GR Adami, T Yoon, ... Mutation Research/DNA Repair 486 (2), 89-97, 2001 | 167 | 2001 |
Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc A Datta, A Nag, W Pan, N Hay, AL Gartel, O Colamonici, Y Mori, ... Journal of Biological Chemistry 279 (35), 36698-36707, 2004 | 147 | 2004 |
A colorimetric assay for estimation of polyethylene glycol and polyethylene glycolated protein using ammonium ferrothiocyanate A Nag, G Mitra, PC Ghosh Analytical biochemistry 237 (2), 224-231, 1996 | 124 | 1996 |
FoxM1: repurposing an oncogene as a biomarker D Nandi, PS Cheema, N Jaiswal, A Nag Seminars in cancer biology 52, 74-84, 2018 | 123 | 2018 |
Cul4A and DDB1 associate with Skp2 to target p27Kip1 for proteolysis involving the COP9 signalosome T Bondar, A Kalinina, L Khair, D Kopanja, A Nag, S Bagchi, ... Molecular and cellular biology, 2006 | 120 | 2006 |
Cul4A physically associates with MDM2 and participates in the proteolysis of p53 A Nag, S Bagchi, P Raychaudhuri Cancer research 64 (22), 8152-8155, 2004 | 109 | 2004 |
Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF A Datta, A Nag, P Raychaudhuri Molecular and cellular biology 22 (24), 8398-8408, 2002 | 87 | 2002 |
CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases P Sharma, A Nag Open biology 4 (2), 130217, 2014 | 80 | 2014 |
An essential role of human Ada3 in p53 acetylation A Nag, A Germaniuk-Kurowska, M Dimri, MA Sassack, CB Gurumurthy, ... Journal of Biological Chemistry 282 (12), 8812-8820, 2007 | 66 | 2007 |
A comprehensive review on miR-200c, a promising cancer biomarker with therapeutic potential S Kumar, A Nag, C C Mandal Current drug targets 16 (12), 1381-1403, 2015 | 55 | 2015 |
Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation G Meng, Y Zhao, A Nag, M Zeng, G Dimri, Q Gao, DE Wazer, R Kumar, ... Journal of Biological Chemistry 279 (52), 54230-54240, 2004 | 54 | 2004 |
Assessment of targeting potential of galactosylated and mannosylated sterically stabilized liposomes to different cell types of mouse liver A Nag, PC Ghosh Journal of drug targeting 6 (6), 427-438, 1999 | 54 | 1999 |
DDB2 induces nuclear accumulation of the hepatitis B virus X protein independently of binding to DDB1 A Nag, A Datta, K Yoo, D Bhattacharyya, A Chakrabortty, X Wang, ... Journal of virology 75 (21), 10383-10392, 2001 | 52 | 2001 |
Effects of depletion of CREB-binding protein on c-Myc regulation and cell cycle G1-S transition HN Rajabi, S Baluchamy, S Kolli, A Nag, R Srinivas, P Raychaudhuri, ... Journal of Biological Chemistry 280 (1), 361-374, 2005 | 48 | 2005 |
Colocynth extracts prevent epithelial to mesenchymal transition and stemness of breast cancer cells K Chowdhury, A Sharma, S Kumar, GK Gunjan, A Nag, CC Mandal Frontiers in pharmacology 8, 593, 2017 | 42 | 2017 |
Ada3 requirement for HAT recruitment to estrogen receptors and estrogen-dependent breast cancer cell proliferation A Germaniuk-Kurowska, A Nag, X Zhao, M Dimri, H Band, V Band Cancer research 67 (24), 11789-11797, 2007 | 41 | 2007 |
Significance of human microbiome in breast cancer: Tale of an invisible and an invincible J Chadha, D Nandi, Y Atri, A Nag Seminars in Cancer Biology 70, 112-127, 2021 | 40 | 2021 |
Mammalian alteration/deficiency in activation 3 (Ada3) is essential for embryonic development and cell cycle progression S Mohibi, CB Gurumurthy, A Nag, J Wang, S Mirza, Y Mian, M Quinn, ... Journal of Biological Chemistry 287 (35), 29442-29456, 2012 | 37 | 2012 |